
|Articles|April 22, 2008
Colesevelam now included in ACE/AACE guide as combination therapy for glycemic control
Bile sequestrant colesevelam now included in endocrinologist groups' diabetes guide.
Advertisement
The American College of Endocrinologists (ACE) and the American Association of Endocrinologists (AACE) have included colesevelam (Welchol, Daiichi Sankyo), a bile acid sequestrant, as an option for treating patients with Type 2 diabetes in their Road Maps to Achieve Glycemic Control in
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
2
Vaccine Policy in Flux: Stories Pharmacists Need to Follow
3
Q&A: Pharmacists Help Patients Navigate Pneumococcal Vaccine Options
4
Pharmacists Are Essential Drivers of Opioid Stewardship Programs
5






























